Related Experiment Video
Updated: Aug 12, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Alterations in G1/S cell-cycle control contributing to carcinogenesis
1Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. William_Kaelin@dfci.harvard.edu
Abstract:
Mutations involving the retinoblastoma tumor-suppressor gene (RB-1) have been described in a variety of human neoplasms. In addition, many tumors that retain a wild-type RB-1 allele harbor mutations that indirectly impair the function of the RB-1 gene product (pRB). pRB is a nuclear protein that regulates cell-cycle progression and, in at least certain tissues, differentiation. The former has been linked to its ability to form complexes with members of the E2F transcription factor family. E2F DNA-binding sites have been identified in the regulatory regions of a number of genes involved in cell-cycle progression. pRB-E2F complexes actively repress transcription when bound to these sites. All tumor-derived pRB mutants have lost the ability to bind to E2F. Conversely, activation of E2F-responsive genes is sufficient to overcome a pRB-induced cell-cycle block and, in certain cell types, can lead to transformation. Thus, E2F appears to be a physiologically relevant target of pRB action, and deregulation of E2F-responsive genes is a common, and possibly universal, step in human carcinogenesis.
Insights
Mutations in the retinoblastoma gene (RB-1) and its protein product (pRB) are common in cancer. Impaired pRB function disrupts cell-cycle control by affecting E2F transcription factors, promoting tumor development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The retinoblastoma tumor-suppressor gene (RB-1) and its protein product (pRB) play crucial roles in regulating cell proliferation and differentiation.
- Dysregulation of RB-1 and pRB function is implicated in various human cancers.
- pRB's interaction with E2F transcription factors is central to its tumor-suppressive activity.
Purpose of the Study:
- To investigate the role of RB-1 gene mutations and indirect functional impairments of pRB in human neoplasms.
- To elucidate the mechanism by which pRB regulates cell-cycle progression through its interaction with E2F transcription factors.
- To determine the significance of E2F deregulation in human carcinogenesis.
Main Methods:
- Analysis of RB-1 gene mutations in tumor samples.
- Assessment of pRB protein function, including its ability to bind E2F transcription factors.
- Examination of E2F-responsive gene expression in tumors with wild-type and mutated RB-1 alleles.
Main Results:
- Mutations in the RB-1 gene are found in numerous human tumors.
- Tumor-derived pRB mutants consistently lose the ability to bind E2F.
- Activation of E2F-responsive genes can bypass pRB-mediated cell-cycle arrest and induce cellular transformation.
Conclusions:
- pRB-E2F complex formation is essential for repressing transcription of cell-cycle-related genes.
- Deregulation of E2F-responsive genes, driven by impaired pRB function, is a critical event in human cancer development.
- Targeting the pRB-E2F pathway may offer therapeutic strategies for various neoplasms.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
The Cell Cycle Control System
Inhibition of Cdk Activity
DNA Damage Can Stall the Cell Cycle
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...

